ArticleJournal of the American Society of Nephrology : JASN2025
Long-Term Benefits and Safety of Statins in Patients with Kidney Failure: A Target Trial Emulation Study.
Article in Journal of the American Society of Nephrology : JASN, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Peritonitis and Mortality Risks of Gastric Acid Suppressants in Patients Undergoing Peritoneal Dialysis.Kidney international reports · 2026Article
- Reno-protective effects of statins among patients with chronic kidney disease in Hong Kong: a target trial emulation.EClinicalMedicine · 2026Article
- Statins' Efficacy Controversy in Kidney Failure: Reassessing Safety and Dialysis Stratification Need.Journal of the American Society of Nephrology : JASN · 2025Article
- Authors' Reply: Statins' Efficacy Controversy in Kidney Failure: Reassessing Safety and Dialysis Stratification Need.Journal of the American Society of Nephrology : JASN · 2025Article
- Methodological Considerations to Enhance the Relevance of Causal Observational Research in the Field of Kidney Disease.Journal of the American Society of Nephrology : JASN · 2025Article
- Author's Reply: Methodological Considerations to Enhance the Relevance of Causal Observational Research in the Field of Kidney Disease.Journal of the American Society of Nephrology : JASN · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.